Royal Bank of Canada reiterated their sector perform rating on shares of Colgate-Palmolive (NYSE:CL - Free Report) in a research note published on Wednesday,Benzinga reports. They currently have a $101.00 price objective on the stock.
Several other equities research analysts have also issued reports on the stock. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research report on Monday, January 6th. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a research report on Friday, January 17th. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a report on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $102.00.
Check Out Our Latest Analysis on CL
Colgate-Palmolive Stock Down 4.7 %
Shares of CL traded down $4.25 during midday trading on Wednesday, hitting $86.64. The stock had a trading volume of 11,098,695 shares, compared to its average volume of 4,547,090. The firm has a market cap of $70.78 billion, a price-to-earnings ratio of 24.82, a price-to-earnings-growth ratio of 3.70 and a beta of 0.44. The company has a 50 day simple moving average of $91.35 and a two-hundred day simple moving average of $97.17. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period in the previous year, the business posted $0.87 EPS. On average, analysts anticipate that Colgate-Palmolive will post 3.58 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's payout ratio is 57.31%.
Insider Buying and Selling at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.34% of the company's stock.
Institutional Trading of Colgate-Palmolive
Large investors have recently bought and sold shares of the business. State Street Corp grew its position in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after purchasing an additional 557,492 shares during the last quarter. Barclays PLC increased its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. Finally, FMR LLC raised its holdings in Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after buying an additional 2,674,807 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report